Results 71 to 80 of about 611,547 (259)

Blue-shifted ancyromonad channelrhodopsins for multiplex optogenetics

open access: yeseLife
Abstract Light-gated ion channels from protists (channelrhodopsins or ChRs) are optogenetic tools widely used for controlling neurons and cardiomyocytes. Multiplex optogenetic applications require spectrally separated molecules, which are difficult to engineer without disrupting channel function.
Elena G Govorunova   +12 more
openaire   +4 more sources

„Hloubání a voda jsou navždy spjaty“: Vzestup modré ekokritiky [PDF]

open access: yesSvět Literatury
The article introduces blue ecocriticism into Czech literary studies by reviewing Steve Mentz’s volume An Introduction to the Blue Humanities (2023). It briefly outlines the circumstances of the cultural turn to the seas and oceans around the year 2000 ...
Ondřej Macl
doaj   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Blue-shift photoconversion of near-infrared fluorescent proteins for labeling and tracking in living cells and organisms. [PDF]

open access: yesNat Commun, 2023
Pennacchietti F   +9 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Ultralow-threshold laser and blue shift cooperative luminescence in a Yb3+ doped silica microsphere

open access: yesAIP Advances, 2014
An experimental investigation on ultralow threshold laser and blue shift cooperative luminescence (CL) in a Yb3+ doped silica microsphere (YDSM) with continuous-wave 976 nm laser diode pumping is reported.
Yantang Huang   +3 more
doaj   +1 more source

Unraveling the blue shift in porphyrin fluorescence in glioma: The 620 nm peak and its potential significance in tumor biology. [PDF]

open access: yesFront Neurosci, 2023
Suero Molina E   +6 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Blue-shifting, asymmetric quantum wells

open access: yesElectronics Letters, 1996
Asymmetric, (100) blue-shifting quantum wells have been fabricated using δ-doped layers at each well-barrier interface. The photoluminescence peaks depend on the δ-dopant concentration as predicted, and blue shifts of 38 nm have been measured for a factor 20 increase in optical pump power.
C. Cooper, D.I. Westwood, P. Blood
openaire   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy